Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists

Recombinant human erythropoietin (rHuEPO) has been used as a performance‐enhancing agent by athletes in a variety of sports. The resulting increase in hematocrit levels leads to increased blood viscosity and can affect blood flow, potentially increasing the athlete's risk of developing health c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Physiol Rep
Asıl Yazarlar: Birkhoff, Willem A. J., Heuberger, Jules A. A. C., Post, Titiaan E., Gal, Pim, Stuurman, Frederik E., Burggraaf, Jacobus, Cohen, Adam F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308108/
https://ncbi.nlm.nih.gov/pubmed/30592183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13924
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller